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Introduction 
Dioxin is a general term often used to describe a group of compounds that belong to the larger 
family of persistent organic pollutants (POPs).  These include polychlorinated dibenzo-p-dioxins 
(PCDDs), polychlorinated dibenzofurans (PCDFs) and dioxin-like polychlorinated biphenyls 
(PCBs).  In this paper, these three groups of compounds will be referred to as dioxin-like 
compounds.  POPs include some of the most toxic chemicals and long-term exposure has been 
associated with adverse health effects including carcinogenesis, endocrine disruptive properties, 
immune system effects and developmental impacts1.  Physico-chemical properties of these 
compounds result in their extreme persistence in the environment, their ubiquitous distribution 
from sources to remote areas via long range atmospheric transport and their ability to 
bioaccumulate and biomagnify in higher trophic organisms.  Typically, more than 90% of the POP 
body burden in humans and other mammals is accumulated via food, in particular seafood, meat 
and dairy products2,3,4. 
 
Methods 
Sampling 
The project was designed on the basis of a request to tender from the Australian Government 
Department of Environment and Heritage Environment (DEH) to assess the levels of dioxin-like 
compounds in the blood serum of the Australian population.  This project was submitted to the 
University of Queensland Medical Research Ethics Committee and approval was obtained on the 
20th September 2002.  Serum samples were collected by a Brisbane based private pathology 
company, Sullivan and Nicolaides Pathology, from stored sera that had been collected as part of 
their routine testing procedures.  It should be noted that throughout this paper serum specimens are 
referred to as samples.   Samples were obtained according to the stratification criteria outlined 
below. 
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Age Stratification 
• <16 years 
• 16-30 years 
• 31-45 years 
• 46-60 years 
• > 60 years. 
 
Gender Stratification 
• Female  
• Male  
 
Geographic Stratification 
• Four urban regions: 
– Northeast (including Brisbane, Tweed and Gold Coast and major population centres in 
Queensland); 
– Southeast (Sydney, Canberra, Wollongong, Newcastle and other major population centres 
from New South Wales); 
– South (Melbourne, Adelaide, Hobart and other major population centres from Victoria); 
– West (Perth and other major population centres in Western Australia) 
• One rural region: including rural areas from all States and the Northern Territory.  Rural areas 
were defined as those postcodes outside metropolitan or major regional centres 
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Figure 1 .  The geographic regions from which samples were collected. 
 
In total, 9090 samples from the 50 strata were collected and pooled to give 96 pools according to 
the above criteria.  An additional 204 samples, representing four pools, were also assessed as part 
of a pilot study to determine the suitability of the use of surplus pathology samples for this study 
(data not shown).  Figure 1 shows the regions of Australia from which samples were obtained. 
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Analysis 
Methodologies for analysis of PCDD/Fs in blood are described in detail elsewhere5,6. 
 
Results and Discussion 
The results of this study provide a measure of the levels of dioxin-like compounds (PCDDs, PCDFs 
and PCBs) in pooled blood serum collected throughout Australia in 2003.  De-identified samples 
were selected from surplus pathology samples according to stratification criteria outlined above. 
 
All pooled samples were sent to ERGO- Forschungsgesellschaft mbH, Hamburg, and 10 duplicate 
samples were sent to Health Canada, Ottawa, Canada for inter-laboratory comparison. Both are 
laboratories accredited for analytical dioxin analysis.  Dioxin-like compounds were detected in all 
strata. The levels of upper bound TEQ found in Australian serum are summarized in Table 1.  
Figure 2 gives an example of the results obtained in this study.   
 
 
Table 1.  Australian serum upper bound TEQ (pg/g lipid), (PCDD, PCDF and PCB) Pool (P) 1 
and 2 by region, gender and age. 
 
  Northeast 
Urban 
Southeast 
Urban 
South 
Urban 
West 
Urban 
Rural 
Area 
Gender Age 
(years) 
P 1 P 2 P 1 P 2 P 1 P 2 P 1 P 2 P 1 P 2 
<16 5.9 5.6 8 5.8 6.1 N/A 6.5 N/A 6.5 6 
Mean (SD) 5.8 (0.2) 6.9 (1.6) N/A N/A 6.3 (0.4) 
16-30 5.8 5 5.9 7.6 6 5.4 4.7 4.9 5.3 6.6 
Mean (SD) 5.4 (0.6) 6.8 (1.2) 5.7 (0.4) 4.8 (0.1) 6.0 (0.9) 
31-45 7.2 7.3 8.2 11 6.5 8.1 7.7 9.8 7.1 8 
Mean (SD) 7.3 (0.1) 9.6 (2.0) 7.3 (1.1) 8.8 (1.5) 7.6 (0.6) 
46-60 12 15 13 14 14 12 11 10 12 12 
Mean (SD) 13.5 (2.1) 13.5 (0.7) 13.0 (1.4) 10.5 (0.7) 12.0 (0.0) 
>60 17 19 22 18 19 20 18 19 16 19 
Males 
Mean (SD) 18.0 (1.4) 20.0 (2.8) 19.5 (0.7) 18.5 (0.7) 17.5 (2.1) 
<16 5.5 5.3 6.3 7.3 4.6 N/A 5.9 N/A 8.3 6.8 
Mean (SD) 5.4 (0.1) 6.8 (0.7) N/A N/A 7.6 (1.1) 
16-30 5.8 6.1 7.1 8.1 6 4.9 4.8 5.3 6.1 6.5 
Mean (SD) 6.0 (0.2) 7.6 (0.7) 5.5 (0.8) 5.1 (0.4) 6.3 (0.3) 
31-45 9 7.7 14 11 7.3 7.6 7.2 7.2 8.6 9.8 
Mean (SD) 8.4 (0.9) 12.5 (2.1) 7.5 (0.2) 7.2 (0.0) 9.2 (0.8) 
46-60 14 12 15 16 11 10 9.7 9.9 12 12 
Mean (SD) 13.0 (1.4) 15.5 (0.7) 10.5 (0.7) 9.8 (0.1) 12.0 (0.0) 
>60 25 22 25 28 21 19 19 21 22 27 
Females 
Mean (SD) 23.5 (2.1) 26.5 (2.1) 20.0 (1.4) 20.0 (1.4) 24.5 (3.5) 
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Figure 2.   Levels of PCDDs, PCDFs and PCBs (total TEQ) in the serum of a representative group 
of the Australian population. Data shown represent average upper bound TEQ values for two 
pooled samples obtained for males and females from the Southeast urban region over the five age 
groups. 
 
Overall the levels in the Australian population are very low by international standards and 
comparable with, although lower than, those observed in the New Zealand population, a country 
with similar potential for exposure to these compounds7.  It should be noted that the samples 
analysed for the New Zealand study were collected in 1996-97, and given that the measured levels 
of these compounds in humans are continuing to decrease over time, this may account for some of 
difference.   The mean and median levels of dioxin-like compounds (PCDD/F and PCB) expressed 
as TEQ values for all pooled samples were 10.9 pg TEQ /g lipid and 8.3 pg TEQ /g lipid.  For 
males and females the mean levels were 10.4 pg TEQ/g lipid and 11.5 pg TEQ /g lipid, 
respectively.  A comparison of the levels of PCDD/Fs and PCBs obtained in this study with 
representative international examples is given in Figure 3a and 3b. 
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Figure 3a Levels of sum PCDD/Fs in various countries 7,8,9,10. 
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Figure 3b Levels of PCB 126 and PCB 169 in various countries 7,9,11,12. 
 
A direct relationship of increasing dioxin-like compound levels with increasing age was observed 
and could be described by the following equation: 
 
Levels in blood expressed as pg TEQ/g lipid = 3.3 exp0.0251age     (r2 = 0.87) 
 
This relationship was found to hold from approximately 25 years of age until at least the eighth 
decade and thus during these years it is possible to estimate the level of dioxin-like compounds in 
an individual’s blood serum. 
 
No systematic differences were observed in the levels of dioxin-like compounds in samples 
collected from males and females.  However, slightly higher levels of dioxin-like compounds were 
observed in females in the >60 years age group.  This result could not be explained on the basis of 
differences in the mean age between males and females in this group. 
 
Some general trends were noted and include the following: 
 
• the levels of dioxin-like compounds across all regions and within each age range appear to 
be very similar; 
• despite the similarity in levels, for all strata except the < 16 years females, the samples 
from the Southeast region exhibit slightly higher levels of dioxin-like compounds; and 
• for < 16 years females the highest levels of dioxin-like compounds were found in the 
Rural region. 
 
It should be noted that because de-identified samples were used in this study, determination of 
regional differences was complicated.  The use of such samples did not allow any assessment of the 
length of time an individual had resided in a particular area prior to their sample being collected or 
recording of either food intake or possible exposure to environmental contaminants in that region. 
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In summary, the levels of dioxin-like compounds in the Australian population are low by 
international standards and are very similar across all regions of Australia within each designated 
age range.  The levels of these chemicals increase with age and can be estimated if the age of an 
individual is known. 
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